BDBM246870 US10053465, 9::US10065963, Compound 9::US10125150, Example 9::US10336759, # 9::US10479803, Example 9::US10675284, Example 9::US11084822, Example 9::US11130767, # 9::US11136326, Example 9::US11285140, Example 85::US11304949, Compound 3::US11324749, Comp. No. 3::US11406640, Comp. No. 3::US11596632, Comp. No. 3::US20240058343, Compound 3::US9732097, Example 9::US9999619, Example 86::[3-[4-(7H- pyrrolo[2,3- d]pyrimidin-4-yl)- 1H-pyrazol-1-yl]-1- (1-{[2- (trifluoromethyl) pyrimidin-4- yl]carbonyl} piperidin-4-yl) azetidin-3- yl]acetonitrile

SMILES FC(F)(F)c1nccc(n1)C(=O)N1CCC(CC1)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12

InChI Key InChIKey=QFPGZAJRDFHPCE-UHFFFAOYSA-N

Data  26 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 246870   

TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM246870(US10053465, 9 | US10065963, Compound 9 | US1012515...)
Affinity DataIC50: <10nMAssay Description:JAK1 pathway inhibitors that can be used for the treatment of cytokine-related diseases or disorders are tested for inhibitory activity of JAK target...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent